ARG2 and diabetes mellitus: Most notably, both ARG1 and ARG2 have been identified as crucial modulators in the pathogenesis of DM complications [52, 100–102], and targeting arginase is capable of improving macrovascular and microvascular complications in DM patients [15, 16, 103, 104] (Table 1) (Figure 3).